Bridge to Life Secures FDA De Novo Clearance for VitaSmart HOPE System in Liver Transplantation
Bridge to Life has received FDA De Novo clearance for its VitaSmart HOPE System, creating a new regulatory pathway for hypothermic oxygenated perfusion in US liver transplantation.
HOPE System | 21/01/2026 | By News Bureau | 121
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy